HLA-G and plasma cell myeloma: On the basis of their results, the authors concluded that the incidence of AKI following contrast media administration in patients with multiple myeloma with a normal SCr is low and correlates with β2-microglobulin levels; thus, the administration of contrast agents in these patients is relatively safe.